You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 20, November 23/30, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Nutritional and Metabolic Disorders, Other
 •Cardiovascular System
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Insulin Resistance and Congestive Heart Failure—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We agree with Dr Stefan and colleagues that adiponectin may play an important role in the associations between obesity, insulin resistance, and CHF. In a recent animal study, the links between low adiponectin levels, insulin resistance, and heart failure were investigated.1 In adiponectin knockout mice, there were increases in insulin resistance, cardiac mass, left ventricular dimensions, and pulmonary congestion compared with control mice. These results are consistent with those of the study by Shibata et al2 and add to the evidence of an association between insulin resistance, adiponectin, and cardiac function. There is still a lack of human studies, but we consider this suggested mechanism at least as reasonable as the ones we suggested in our article. However, there is a need for further studies to elucidate the causative relations and mechanisms involved in the associations between obesity, insulin resistance, and CHF. These mechanisms could include adiponectin deficiency, . . . [Full Text of this Article]

Erik Ingelsson, MD
erik.ingelsson@pubcare.uu.se

Johan Sundström, MD, PhD; Johan Ärnlöv, MD, PhD; Björn Zethelius, MD, PhD
Department of Public Health and Caring Sciences

Lars Lind, MD, PhD
Department of Medical Sciences
Uppsala University
Uppsala, Sweden



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Insulin Resistance and Congestive Heart Failure
Norbert Stefan, Andreas Fritsche, and Hans-Ulrich Häring
JAMA. 2005;294(20):2578.
EXTRACT | FULL TEXT  

Insulin Resistance and Risk of Congestive Heart Failure
Erik Ingelsson, Johan Sundström, Johan Ärnlöv, Björn Zethelius, and Lars Lind
JAMA. 2005;294(3):334-341.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.